Search for: "Lamb"
Results 521 - 540
of 3,762
Sorted by Relevance
|
Sort by Date
26 Sep 2012, 10:20 am
Use Of Pradaxa After ACS Is Associated With Increased Rate Of Major Bleeding, And Concomitant Use Of Pradaxa With Multaq Is Contraindicated (Posted by Tom Lamb at DrugInjuryWatch.com) When Pradaxa (dabigatran) is used to prevent thrombotic events after an acute coronary syndrome (ACS), it is associated with increased rates of major bleeding that offsets any antithrombotic benefit, according to a September 24, 2012 (Online First) Archives of Internal Medicine article, "Use of… [read post]
29 Sep 2009, 10:06 am
(Posted by Tom Lamb at DrugInjuryWatch.com) On September 25, 2009 the FDA posted on its web site "Information for Healthcare Professionals - Acute pancreatitis and sitagliptin (marketed as Januvia and Janumet)". [read post]
30 May 2012, 1:37 pm
Researchers Find Increased Number Of Low-Energy Subtrochanteric Fractures For A Period Ten Years After Introduction Of Fosamax In That Country (Posted by Tom Lamb at DrugInjuryWatch.com) At the Orthopaedic Proceedings section of the Journal of Bone & Joint Surgery, British Volume, web site there is an item that presents some findings from a recent Australian study which supports the apparent link between Fosamax and atypical femur fractures. [read post]
12 Feb 2007, 11:12 am
New Package Insert, Or Label, For Ketek Will Get Black-box Warning And Medication Guide For Patients, Also (Posted by Tom Lamb at DrugInjuryWatch.com) In mid-December 2006 an FDA advisory panel recommended that any future use of the antibiotic Ketek should be restricted. [read post]
6 Feb 2008, 3:00 am
Lamb says law firms are in the "perfect storm": clients are angry at law firms and want to cut their spending for outside legal services.I call it a recession. [read post]
12 Oct 2009, 2:07 pm
Is Pancreatitis A Januvia Side Effect Or Is There An Increased Risk Of This Medical Condition Among Type 2 Diabetics Across All Treatments (Posted by Tom Lamb at DrugInjuryWatch.com) A few weeks back we reported that the FDA wants Merck to change the package insert, or label, for the diabetes drug Januvia (sitagliptin) so as to show an increased warning about the risk of developing pancreatitis. [read post]
28 Sep 2011, 1:43 pm
Possibly Increased Risk Of Blood Clot-Related Side Effects Like PE And DVT Suggested By Postmarketing Studies (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: Ortho Evra Update: October 2011 FDA Study Finds Increased Risk Of Serious Blood Clot Side Effects Like Pulmonary Embolism (PE) And Deep Vein Thrombosis (DVT) (11/2/11) _____________________________________________________________________ On December 9, 2011… [read post]
30 Jul 2007, 12:11 am
Read Selected Essays From 77 Diverse Legal Blogs (aka Blawgs) In This Free eBook From TechnoLawyer (Posted by Tom Lamb at DrugInjuryWatch.com) On July 30, 2007 TechnoLawyer issued a press release announcing the launch of BlawgWorld 2007, a free eBook that features a diverse and impressive collection of essays from the so-called legal blogosphere. [read post]
30 May 2012, 1:37 pm
Researchers Find Increased Number Of Low-Energy Subtrochanteric Fractures For A Period Ten Years After Introduction Of Fosamax In That Country (Posted by Tom Lamb at DrugInjuryWatch.com) At the Orthopaedic Proceedings section of the Journal of Bone & Joint Surgery, British Volume, web site there is an item that presents some findings from a recent Australian study which supports the apparent link between Fosamax and atypical femur fractures. [read post]
24 Aug 2009, 1:30 pm
FDA Early Communication Makes Clear That No Definite Association Between Liver Injury And Orlistat Has Been Established At This Time (Posted by Tom Lamb at DrugInjuryWatch.com) On May 22, 2009 we first reported that the FDA is investigating the obesity drugs Xenical and Alli for a possible link with liver damage. [read post]
9 Oct 2012, 2:37 pm
Concomitant Use Of Tekturna With ACE Inhibitors And ARBs Contraindicated In Patients With Diabetes; Plus An FDA Caution Regarding Renal Impairment (Posted by Tom Lamb at DrugInjuryWatch.com) Tekturna (aliskiren) was approved by the FDA for marketing in March 2007 after it was evaluated for safety in 6,460 patients, and only 1250 patients were treated for longer than 1 year. [read post]
15 Jan 2007, 9:24 am
One Injury (Humeston) And One Death (Hermans) Case Involving Heart Attacks After Vioxx Use Will Go Before Jury (Posted by Tom Lamb at DrugInjuryWatch.com) In a January 13, 2007 Bloomberg article by David Voreacos we learned that Judge Carol Higbee has cut the Carver and Kieley cases from the consolidated Vioxx trial that is starting later this month. [read post]
30 Mar 2009, 1:35 pm
This Event In Support Of Proposed Medical Device Safety Act Is Organized By The "Campaign to Stop Corporate Immunity" Group (Posted by Tom Lamb at DrugInjuryWatch.com) The Campaign to Stop Corporate Immunity (CSCI) group has arranged for some patients injured by defective medical devices -- such as the recalled Medtronic Sprint Fidelis lead wires that were used in certain defibrillators -- to be in Washington, DC on Tuesday, March 31, 2009 for the purpose of "showing"… [read post]
26 Mar 2007, 2:53 pm
The Letter Concerns Black-Box Warning, Prescribing Changes, And Patient Medication Guide Announced Back In Mid-February 2007 (Posted by Tom Lamb at DrugInjuryWatch.com) On March 26, 2007 the FDA announced that a so-called "Dear Doctor" letter regarding the antibiotic Ketek (telithromycin) has been sent by Sanofi-Aventis to healthcare professionals alerting them to new safety information for Ketek. [read post]
5 Mar 2012, 1:05 pm
Prescriber Error, Impaired Renal Function, Patient Age, And Lack Of An Effective Reversal Agent Are Cited (Posted by Tom Lamb at DrugInjuryWatch.com) A Letter to The Editor, titled "Bleeding Risk with Dabigatran in the Frail Elderly" (subscription required), which appeared in the March 1, 2012 edition of the New England Journal of Medicine (NEJM) may help explain when and why there is a serious bleeding risk associated with Pradaxa (dabigatran). [read post]
15 Feb 2008, 2:30 pm
Action Reportedly Intended To Emphasize 2007 Label Change About Severe, Possibly Fatal Liver And Skin Side Effects (Posted by Tom Lamb at DrugInjuryWatch.com) A February 14, 2008 Reuters article, "Bayer warns doctors on rare Avelox side effects", reports that this German drug company is sending warning letters to doctors in Europe about the antibiotic Avelox, one of its top-selling drugs. [read post]
10 Mar 2009, 11:11 am
Agency Publishes Notice In March 9 Edition Of The Federal Register: Seeking Public Comment On Proposed Voluntary Survey (Posted by Tom Lamb at DrugInjuryWatch.com) In May 2008 the FDA published a white paper, "The Sentinel Initiative - A National Strategy for Monitoring Medical Product Safety", that served to introduce and explain this new agency effort intended to to improve the post-approval monitoring of prescription drugs and medical devices. [read post]
8 Sep 2009, 12:20 pm
Healthcare Providers And Patients Are Encouraged To Report Adverse Events Involving Approved Or Unapproved Indications As Well As Medication Errors (Posted by Tom Lamb at DrugInjuryWatch.com) In October 2006 Quintiles Inc., a leading CRO company, conducted a survey titled "Consumer Perceptions on Drug Safety" that consisted of 1726 US men and women aged 18 years and over. [read post]
11 Apr 2009, 3:37 am
View the article here 04/11/2009 Your series of articles highlighting the difficulty in placing James Lamb in Monterey County confirms The Herald's editorial view of Feb. 5 that sex offender laws are wholly impractical. [read post]
27 Aug 2007, 7:36 pm
MY OLD LAW FIRM, DEWEY BALLANTINE, will now be Dewey & LeBoeuf, as the result of a merger with LeBoeuf Lamb. [read post]
